Study guide

13.1 High Spinal / Total Spinal Anesthesia & Aspiration Pneumonitis

C-OBE Obstetric Emergencies Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Maternal Assessment, Risk Stratification & Early Warning Systems

1.1 Pre-Existing Medical, Surgical & Obstetric Comorbidities in Emergency Risk Stratification 1.2 Dynamic Antepartum & Intrapartum Risk Assessment 1.3 Maternal Early Warning Systems (MEWS/MEWT) & Critical Triage Physical Assessment 1.4 Alliance for Innovation on Maternal Health (AIM) Safety Bundles & Emergency Readiness

2 Chapter 2: Obstetric Hemorrhage — Etiology, Assessment & Uterotonics

2.1 Postpartum Hemorrhage Etiology (4 T's) & Quantitative Blood Loss (QBL) 2.2 Uterotonic Pharmacology & Stepwise Administration Protocols 2.3 Tranexamic Acid (TXA) Protocols & Hemorrhage Timing

3 Chapter 3: Obstetric Hemorrhage — Mechanical Interventions, Placental Disorders & Transfusion

3.1 Intrauterine Tamponade Balloons, Compression Sutures & Surgical Hemostasis 3.2 Ectopic Pregnancy, Placenta Previa, Accreta Spectrum (PAS), Abruption & Vasa Previa 3.3 Obstetric DIC, Coagulopathy & Massive Transfusion Protocol (MTP)

4 Chapter 4: Hypertensive Disorders of Pregnancy & Preeclampsia with Severe Features

4.1 Classification & Spectrum of Hypertensive Disorders of Pregnancy 4.2 Preeclampsia with Severe Features: Pathophysiology & End-Organ Damage 4.3 Diagnostic Evaluation, Laboratory Triggers & Fetal Surveillance in Preeclampsia

5 Chapter 5: Hypertensive Crisis, Eclampsia & Magnesium Sulfate Therapy

5.1 Acute Severe Hypertension & First-Line Antihypertensive Protocols 5.2 Eclampsia Recognition, Seizure Management & Airway Protection 5.3 Magnesium Sulfate Neuroprotection/Seizure Prophylaxis Protocols, Monitoring & Toxicity Reversal 5.4 HELLP Syndrome & Hepatic Crisis Management

6 Chapter 6: Maternal Resuscitation, Cardiac Arrest & Perimortem Cesarean

6.1 Maternal ACLS Modifications & Cardiopulmonary Resuscitation Physiology 6.2 Etiologies of Maternal Arrest & Structured Emergency Response 6.3 Perimortem Cesarean Delivery (PMCD / Resuscitative Hysterotomy)

7 Chapter 7: Amniotic Fluid Embolism & Maternal Shock States

7.1 Amniotic Fluid Embolism (AFE): Pathophysiology & Clinical Presentation 7.2 A-OK Protocol, Hemodynamic Support & Critical Care in AFE 7.3 Maternal Shock States: Hemorrhagic, Distributive, Cardiogenic & Obstructive

8 Chapter 8: Acute Intrapartum Delivery Emergencies

8.1 Shoulder Dystocia: Recognition, Timing & Primary HELPERR Sequence 8.2 Advanced Shoulder Dystocia Maneuvers & Neonatal Brachial Plexus Injury Prevention 8.3 Umbilical Cord Prolapse Recognition & Emergent Decompression Protocols

9 Chapter 9: Uterine Inversion, Malpresentation & Obstetric Trauma

9.1 Acute Uterine Inversion: Recognition, Tocolysis & Manual/Surgical Reduction 9.2 Emergency Vaginal Breech Extraction & Head Entrapment Maneuvers 9.3 Maternal Trauma: Primary/Secondary Survey, Placental Abruption & Fetomaternal Hemorrhage

10 Chapter 10: Maternal Sepsis, Intraamniotic Infection & Severe Infections

10.1 Maternal Sepsis: Physiological Criteria, S.O.S. Score & omSOFA 10.2 The Maternal Sepsis Hour-1 Bundle & Fluid/Vasopressor Optimization 10.3 Intraamniotic Infection (Triple I / Chorioamnionitis) & Severe Endometritis 10.4 Severe Pyelonephritis, Maternal Pneumonia & Severe Peripartum Infections

11 Chapter 11: Endocrine, Cardiovascular, Respiratory & Neurologic Emergencies

11.1 Diabetic Ketoacidosis (DKA), Maternal Hypoglycemia & Endocrine Resuscitation in Pregnancy 11.2 Peripartum Cardiomyopathy (PPCM), Acute Heart Failure, Acute Coronary Syndromes & Maternal Arrhythmias 11.3 Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy 11.4 Status Epilepticus, Acute Stroke & Cerebral Venous Sinus Thrombosis (CVST)

12 Chapter 12: Thromboembolism, Hepatorenal Disorders & Toxicologic Emergencies

12.1 Venous Thromboembolism (DVT/PE) Diagnosis, Treatment & Peripartum Anticoagulation 12.2 Acute Fatty Liver of Pregnancy (AFLP / Swansea Criteria) & Acute Kidney Injury 12.3 Peripartum Substance Overdose, Opioid Toxicity & Naloxone Administration

13 Chapter 13: Obstetric Anesthesia Emergencies & Critical Complications

13.1 High Spinal / Total Spinal Anesthesia & Aspiration Pneumonitis 13.2 Local Anesthetic Systemic Toxicity (LAST) & 20% Lipid Emulsion Rescue Protocol 13.3 Post-Dural Puncture Headache (PDPH), Epidural Hematoma & Abscess 13.4 Malignant Hyperthermia in Obstetric Anesthesia & Dantrolene Protocol

14 Chapter 14: Professional Practice, Team Communication, Debriefing & Health Equity

14.1 Crisis Resource Management (CRM), TeamSTEPPS & Structured Communication 14.2 Multidisciplinary Emergency Debriefing, Morbidity & Mortality, and Systems Learning 14.3 Perinatal Racial/Ethnic Disparities, Implicit Bias Mitigation & Respectful Maternity Care 14.4 Legal, Ethical, Documentation & EMTALA Standards in Obstetric Emergencies

13.1 High Spinal / Total Spinal Anesthesia & Aspiration Pneumonitis

Key Takeaways Explain This Topic AI

High spinal anesthesia occurs when neuraxial blockade extends cephalad above T4, leading to dyspnea (loss of intercostal and abdominal wall proprioception and muscle power), upper extremity weakness (C5-T1), profound hypotension (systemic sympathectomy), and severe bradycardia due to blockade of the cardiac accelerator fibers originating at T1-T4.

Total spinal anesthesia results from subdural or inadvertent subarachnoid injection of large-dose epidural local anesthetic traversing into intracranial cerebrospinal fluid (CSF), rapidly producing unconsciousness, complete apnea (phrenic nerve C3-C5 paralysis and brainstem ischemia), and bilateral fixed dilated pupils.

Immediate emergency management of high/total spinal anesthesia requires airway stabilization with 100% O2 (escalating to rapid sequence induction and endotracheal intubation if unconscious or hypoxemic), aggressive left uterine displacement (LUD), rapid crystalloid/colloid infusion, and early vasoactive support with Ephedrine, Phenylephrine, or Epinephrine (10-100 mcg IV boluses for profound hypotension/bradycardia).

Mendelson syndrome (aspiration pneumonitis) results from chemical burn injury to pulmonary parenchyma by aspirated gastric contents (pH <2.5, volume >0.4 mL/kg or 25 mL); prevention relies on non-particulate antacid prophylaxis (sodium citrate 30 mL 0.3M), H2-receptor antagonists, Sellick maneuver / cricoid pressure during rapid sequence intubation, and immediate airway suctioning in head-down lateral position if vomiting occurs.

Last updated: August 2026

High Spinal / Total Spinal Anesthesia & Aspiration Pneumonitis

Neuraxial anesthesia (spinal, epidural, and combined spinal-epidural [CSE]) represents the gold standard for labor analgesia and cesarean delivery. However, cephalad migration of local anesthetics beyond intended dermatomal levels can precipitate life-threatening maternal emergencies. Understanding the precise anatomical landmarks, physiological mechanisms of cardiopulmonary compromise, rapid airway management, and prevention of aspiration pneumonitis (Mendelson syndrome) is mandatory for obstetric emergency teams.

1. Pathophysiology of Neuraxial Block Height & Spinal Dermatomes

During cesarean delivery under neuraxial anesthesia, a bilateral sensory block to the T4 dermatome (nipple line) is required to eliminate pain from peritoneal incision, exteriorization of the uterus, and traction on abdominal viscera. However, exaggerated cephalad spread can compromise critical autonomic and somatic functions. +---------------------------------------------------------------------------------------------------+

  • | SPINAL DERMATOME LEVELS & PHYSIOLOGICAL IMPACT |
  • | |
  • | • C3 - C5 DERMATOMES (Phrenic Nerve Roots): |
  • | - Innervates the diaphragm. Blockade causes complete diaphragmatic paralysis and apnea. |
  • | |
  • | • C5 - T1 DERMATOMES (Brachial Plexus): |
  • | - Innervates upper extremities. Blockade causes hand/finger tingling, heaviness, and weakness. |
  • | |
  • | • T1 - T4 DERMATOMES (Sympathetic Cardioaccelerator Fibers): |
  • | - Provides sympathetic tone to the sinoatrial and atrioventricular nodes and myocardium. |
  • | - Blockade eliminates cardiac sympathetic drive -> severe bradycardia, decreased inotropy, |
  • | and precipitate cardiovascular collapse. |
  • | |
  • | • T4 DERMATOME (Nipple Line): |
  • | - Standard target sensory level for cesarean section. Sympathetic blockade extends 2-3 |
  • | segments above sensory level (T1-T2), causing profound peripheral venodilation. |
  • | |
  • | • T10 DERMATOME (Umbilicus): |
  • | - Standard target sensory level for labor analgesia. |
  • +---------------------------------------------------------------------------------------------------+
  • Why Gravid Patients Are at Heightened Risk for Cephalad Spread

Decreased CSF Volume in Subarachnoid Space: Engorgement of the epidural venous plexus (Batson's plexus) secondary to inferior vena cava (IVC) compression by the gravid uterus displaces the dura inward, reducing lumbar cerebrospinal fluid (CSF) volume by up to 30%.

Increased Neural Sensitivity: Elevated circulating progesterone and endogenous endorphins enhance the sensitivity of nerve fibers to local anesthetic molecules.

Altered Spinal Curvature: Exaggerated lumbar lordosis and thoracic kyphosis in late pregnancy alter the dependent flow of hyperbaric local anesthetic solutions.

Inadvertent Subarachnoid or Subdural Catheter Placement: Epidural catheters intended for the potential epidural space may accidentally penetrate the dura or subdural space, delivering massive local anesthetic boluses directly into CSF.

2. Clinical Differentiation: High Spinal vs. Total Spinal vs. Subdural Injection

Recognizing the distinction between high spinal, total spinal, and subdural blocks allows the resuscitation team to anticipate airway loss and cardiovascular collapse.

Parameter High Spinal Anesthesia Total Spinal Anesthesia Subdural Space Injection

Definition Block height extending above T4 to mid-cervical levels (C5-T1) Intracranial cephalad spread into basal cisterns / brainstem Injection into potential space between dura and arachnoid mater

Onset Time Rapid (3–10 minutes) Immediate to rapid (1–5 minutes) Delayed & insidious (15–30 minutes)

Consciousness Fully Conscious , highly anxious, dyspneic Loss of Consciousness , unresponsiveness, coma Variable (initially alert, may slowly become obtunded)

Airway & Respiration Dyspnea, weak cough, inability to phonate loudly; diaphragm intact Complete Apnea (phrenic C3-C5 block + medullary hypoperfusion) Mild to moderate dyspnea; delayed respiratory depression

Pupils Normal, reactive Bilateral Fixed & Dilated (cranial nerve / brainstem ischemia) Normal, reactive

Upper Extremity Power Weakness, heaviness, numbness in hands/arms (C5-T1) Total flaccid quadriplegia Patchy, asymmetrical weakness

Hemodynamics Severe hypotension + severe bradycardia (T1-T4 block) Profound Cardiovascular Collapse , severe bradycardia/asystole Moderate to severe hypotension; unpredictable level

Sensory Block Quality Dense, bilateral, symmetric Dense, total cranial-caudal block Patchy, asymmetrical, sensory-motor dissociation

Clinical Pearl: Dyspnea in a high spinal is primarily caused by loss of chest wall sensation (intercostal and abdominal muscle proprioception) rather than diaphragmatic paralysis. Because the diaphragm is innervated by C3-C5, diaphragmatic excursion remains intact until the block reaches mid-cervical levels. However, patients lose the ability to cough or clear secretions, creating overwhelming sensation of suffocation.

3. Step-by-Step Emergency Resuscitation Protocol +---------------------------------------------------------------------------------------------------+

  • | STEP-BY-STEP HIGH / TOTAL SPINAL PROTOCOL |
  • | |
  • | STEP 1: CALL FOR IMMEDIATE HELP & HALT DRUG DELIVERY |
  • | • Call for anesthesia stat, obstetric team, neonatal resuscitation team, and code cart. |
  • | • Immediately stop all epidural, spinal, and IV opioid/sedative infusions. |
  • | |
  • | STEP 2: AIRWAY AND BREATHING (OXYGENATION FIRST) |
  • | • High Spinal (Conscious, dyspneic): Administer 100% O2 via non-rebreather mask (10-15 L/min). |
  • | Reassure patient, keep head elevated slightly (15-20°) to limit physical cephalad dye spread. |
  • | • Total Spinal (Unconscious, apneic): Initiate immediate Bag-Valve-Mask (BVM) ventilation with |
  • | 100% O2. Proceed to **Rapid Sequence Intubation (RSI)** with cricoid pressure and cuffed ETT. |
  • | |
  • | STEP 3: CIRCULATION & HEMODYNAMIC RESTORATION |
  • | • **Aggressive Left Uterine Displacement (LUD):** Relieve aortocaval compression manually or |
  • | with 15-30° left tilt to restore venous return to the right heart. |
  • | • **Rapid IV Volume Expansion:** Open wide-bore IV lines with crystalloid or colloid under |
  • | pressure bag (1,000–2,000 mL bolus). |
  • | • **Targeted Vasopressor / Inotrope Selection:** |
  • | - If Hypotension with Normal/High Heart Rate: **Phenylephrine 50–100 mcg IV bolus** (alpha-1 |
  • | agonist; increases systemic vascular resistance). |
  • | - If Hypotension with Bradycardia (HR <60 bpm): **Ephedrine 5–10 mg IV bolus** (mixed alpha/ |
  • | beta agonist; restores inotropy and chronotropy). |
  • | - If Severe Refractory Hypotension / Impending Arrest: **Epinephrine 10–100 mcg IV boluses** |
  • | (or 1 mg IV for cardiac arrest). Epinephrine is the definitive rescue drug. |
  • | - Persistent Bradycardia: **Atropine 0.5–1.0 mg IV** or **Glycopyrrolate 0.2–0.4 mg IV**. |
  • | |
  • | STEP 4: FETAL MONITORING & PERIMORTEM CESAREAN CONSIDERATIONS |
  • | • Maintain continuous fetal heart rate monitoring; profound maternal hypotension triggers fetal |
  • | bradycardia due to uterine hypoperfusion. |
  • | • If maternal cardiac arrest occurs and Return of Spontaneous Circulation (ROSC) is not achieved |
  • | within **4 minutes**, perform emergent **Resuscitative Hysterotomy (Perimortem Cesarean)** |
  • | at the bedside to relieve aortocaval compression and optimize maternal CPR efficacy. |
  • +---------------------------------------------------------------------------------------------------+
  • 4. Mendelson Syndrome (Aspiration Pneumonitis) in Pregnancy

Mendelson syndrome, first described by Curtis Lester Mendelson in 1946, is an acute chemical burn of the tracheobronchial tree and lung parenchyma resulting from the inhalation of acidic, sterile gastric contents.

Classical Criteria & Pathophysiology

Critical Gastric Thresholds: Inhalation of gastric volume >25 mL (>0.4 mL/kg) with a pH <2.5 triggers immediate chemical de-epithelialization of alveolar-capillary membranes.

Biphasic Inflammatory Cascades:

Immediate Phase (1–4 hours): Direct acid destruction of type I alveolar pneumocytes and capillary endothelial damage, leading to massive transudation of fluid, intra-alveolar hemorrhage, and non-cardiogenic pulmonary edema.

Delayed Inflammatory Phase (4–24 hours): Infiltration of neutrophils, release of tumor necrosis factor-alpha (TNF-alpha), interleukins (IL-6, IL-8), and reactive oxygen species, progressing to Acute Respiratory Distress Syndrome (ARDS). +---------------------------------------------------------------------------------------------------+

  • | ASPIRATION PNEUMONITIS VS. ASPIRATION PNEUMONIA |
  • | |
  • | • ASPIRATION PNEUMONITIS (Mendelson Syndrome): |
  • | - Etiology: Sterile gastric acid / chemical burn. |
  • | - Onset: Immediate (minutes to 1-2 hours) after aspiration event. |
  • | - Presentation: Sudden bronchospasm, cyanosis, severe hypoxemia, tachypnea, pink frothy sputum|
  • | - Radiography: Bilateral diffuse perihilar or dependent alveolar infiltrates. |
  • | - Treatment: Supportive oxygenation, positive end-expiratory pressure (PEEP), suctioning. |
  • | - **Antibiotics & Corticosteroids:** NOT INDICATED routinely; steroids show no benefit and |
  • | increase secondary infection risks. Prophylactic antibiotics do not improve outcomes. |
  • | |
  • | • ASPIRATION PNEUMONIA: |
  • | - Etiology: Bacterial colonization from oropharyngeal secretions (mixed anaerobes/aerobes). |
  • | - Onset: Delayed (48 to 72 hours) following aspiration. |
  • | - Presentation: Fever, purulent sputum, leukocytosis, localized focal consolidations. |
  • | - Treatment: Targeted antimicrobial therapy (e.g., Ampicillin-Sulbactam or Ceftriaxone). |
  • +---------------------------------------------------------------------------------------------------+
  • Obstetric Factors Increasing Aspiration Risk

Delayed Gastric Emptying: High circulating progesterone delays gastrointestinal motility; active labor and parenteral opioid administration halt gastric emptying entirely.

Reduced Lower Esophageal Sphincter (LES) Tone: Progesterone causes smooth muscle relaxation of the gastroesophageal junction, promoting acid reflux.

Elevated Intragastric Pressure: Gravid uterus shifts gastric axis and elevates intra-abdominal pressure.

Difficult Airway Anatomy: Capillary engorgement, mucosal friability, Mallampati grade worsening during labor, and rapid desaturation due to a 20% reduction in Functional Residual Capacity (FRC) and a 30-40% increase in maternal oxygen consumption.

Pharmacologic Prophylaxis Regimen

Before planned or emergency cesarean delivery under general anesthesia, administered pharmacologic agents neutralize acid and reduce volume:

Non-Particulate Antacid: 0.3 M Sodium Citrate 30 mL orally administered 10–30 minutes pre-induction. (Particulate antacids such as aluminum/magnesium hydroxide are strictly contraindicated because if aspirated, particles cause severe granulomatous foreign-body lung reaction).

H2-Receptor Antagonists: Famotidine 20 mg IV or Ranitidine 50 mg IV (reduces gastric acid secretion; optimal when given >=60 min prior).

Prokinetic Agents: Metoclopramide 10 mg IV (increases lower esophageal sphincter tone and accelerates gastric emptying).

Emergency Management of Acute Aspiration

Immediate Positioning: Lower the head of the bed (Trendelenburg) and turn the patient into the left lateral tilt position to allow fluid to drain out of the mouth and avoid gravitational tracheobronchial flooding.

Aggressive Suctioning: Clear the oropharynx immediately with a large-bore rigid suction catheter (Yankauer). If the patient is intubated, perform immediate tracheal suctioning before positive pressure ventilation is applied (to avoid forcing acid further down into terminal bronchioles).

Mechanical Ventilation: Apply high fraction of inspired oxygen ( F i O 2 FiO_2 F i O 2 ​ ) and titrate Positive End-Expiratory Pressure (PEEP, 5–10 cm H 2 O H_2O H 2 ​ O ) to maintain P a O 2 > 60 mmHg PaO_2 >60\text{ mmHg} P a O 2 ​ > 60 mmHg and recruit atelectatic alveoli.

Bronchodilators: Administer inhaled albuterol/ipratropium for reactive bronchospasm.

Loading diagram... High/Total Spinal Anesthesia & Aspiration Emergency Algorithm